Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Ifenprodil by Seyltx for Chronic Cough: Likelihood of Approval
Ifenprodil is under clinical development by Seyltx and currently in Phase II for Chronic Cough. According to GlobalData, Phase II...